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Available online 14 April 2016Protein folding, topogenesis and intracellular targeting of G protein-coupled receptors (GPCRs)must be precisely
coordinated to ensure correct receptor localization. To elucidate how different steps of GPCR biosynthesis work
together, we investigated the process of membrane topology determination and how it relates to the acquisition
of cell surface trafﬁcking competence in human GPR34. By monitoring a fused FLAG-tag and a conformation-
sensitive native epitope during the expression of GPR34 mutant panel, a tri-basic motif in the ﬁrst intracellular
loop was identiﬁed as the key topogenic signal that dictates the orientation of transmembrane domain-1
(TM1). Charge disruption of the motif perturbed topogenic processes and resulted in the conformational epitope
loss, post-translational processing alteration, and trafﬁcking arrest in the Golgi. The placement of a cleavable N-
terminal signal sequence as a surrogate topogenic determinant overcame the effects of tri-basic motif mutations
and rectiﬁed the TM1 orientation; thereby restored the conformational epitope, post-translationalmodiﬁcations,
and cell surface trafﬁcking altogether. ProgressiveN-tail truncation and site-directedmutagenesis revealed that a
proline-rich segment of the N-tail and all four cysteines individually located in the four separate extracellular re-
gionsmust simultaneously reside in the ER lumen tomuster the conformational epitope. Oxidation of all four cys-
teines was necessary for the epitope formation, but the cysteine residues themselves were not required for the
trafﬁcking event. The underlying biochemical properties of the conformational epitope was therefore the key
to understand mechanistic processes propelled by positive-inside rule that simultaneously regulate the
topogenesis and intracellular trafﬁcking of GPR34.









Recombinantly expressed G protein-coupled receptors (GPCRs) are
valuable tools to study receptor pharmacology and receptor biosynthe-
sis. Heterologous expression of GPCRs in non-native cell host, however,
can pose technical challenges that hamper the efforts to understand
GPCR biology. A well-known example is the case of GPCR retention in
the endoplasmic reticulum (ER) and the subsequent degradation
without allowing it to reach the cell surface [1]. UnproductiveGPCR syn-
thesis like this is widely attributed to the lack of dedicated factors that
are present in the native cellular environment (butmissing in the heter-
ologous cell hosts) to assist the folding and trafﬁcking of client GPCRs
[2–5]. Instead of merely using a constitutive trafﬁcking pathway route,t; ER, endoplasmic reticulum;
bryonic kidney; TCEP, tris(2-
s Blvd, South San Francisco, CA
il.com (H. Hasegawa).
This is an open access article under tsome GPCRs use intracellular compartments (such as Golgi apparatus)
as a physiological reservoir to regulate the amount of GPCRs displayed
on the cell surface [6,7]. Other GPCRs must dimerize with designated
partners before gaining trafﬁcking competence out of the ER [8,9]. Indi-
vidualized strategies that accommodate particular needs of each GPCR
make the recombinant expression of some GPCRs difﬁcult unless
cognate mechanisms are elucidated in advance. Furthermore, while
the majority of GPCRs are targeted to the cell surface, there is a group
of atypical GPCRs that are speciﬁcally localized to the nuclear mem-
brane [10], the ER [11], or the trans-Golgi network [12] to carry out
their functions. These examples collectively outline the diversity of
biosynthetic requirements and the challenges of recombinant GPCR
expression.
While the vast majority of GPCRs do not have the ER-targeting N-
terminal signal sequences, there are outlying GPCR family members
that do possess such cleavable signal peptides [13–15]. GPCRs of this
group typically have a long N-terminal extracellular tail that folds into
a stable globular domain. Deletion of the signal sequence results in the
folding of the entire N-tail region in the cytosol before the emergence
of the ﬁrst transmembrane (TM1) segment from the ribosome. Oncehe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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into the ER lumen becomes much more difﬁcult and this often leads to
aberrant N-terminal topology [14,16,17]. On the contrary, adding an ex-
ogenous signal sequence to the N terminus of the GPCRs that lack this
element can promote higher cell surface expression levels [16,18] and
can even sponsor a cell surface trafﬁcking of “difﬁcult-to-express”
GPCRs that are otherwise retained in the ER [19]. Evidently, depending
onwhether a GPCR has theN-terminal signal sequence or not, the trans-
location of the extracellular N-tail region into the ER lumen takes place
either co-translationally or post-translationally and such difference
alone can inﬂuence the processes of GPCR biosynthesis.
In addition to the N-terminal signal sequence, various types of se-
quence motifs do inﬂuence the topogenesis and trafﬁcking of GPCRs
[20,21]. However, it is not clear how these topogenic signals exert
their effects during the co-translational and post-translational processes
that culminate in the characteristic GPCR topology. Furthermore,
although protein folding, topogenesis and intracellular trafﬁcking
events must be carefully orchestrated to ensure the delivery of GPCRs
to their destination membranes, how these steps are coordinated is
notwell understood. In this study, by taking advantage of a topologically
and conformationally sensitive native epitope, we identiﬁed a tri-basic
motif in the ﬁrst intracellular loop (ICL1) as the key determinant of
topogenesis and cell surface trafﬁcking for human GPR34. Disruption
of this critical motif by charge reversal or charge neutralization muta-
tions rendered GPR34 to (1) alteration of post-translational processing,
(2) loss of the native epitope, and (3) arrest of protein trafﬁcking in the
Golgi compartment. By employing a signal peptide-based surrogate de-
sign, which allows the co-translational translocation of the N-tail into
the ER lumen before the appearance of TM1 from the ribosome, the
TM1 orientation was rectiﬁed despite the absence of tri-basic motif.
The conformational reporter epitope was mapped to a short segment
of the extracellular N-tail region composed of Cys-46 and the adjacent
proline-rich area in conjunction with distantly located three cysteine
residues in the ﬁrst, second, and third extracellular loops. These sepa-
rate elements must come together in the biochemical environment of
the ER lumen in order to mature into a reductant-sensitive native epi-
tope. The unique biochemical properties of the conformational epitope
served as a tool to uncover simple mechanistic processes that simulta-
neously regulate GPR34 topogenesis and trafﬁcking.
2. Materials and methods
2.1. Chemicals, detection antibodies, and reagents
All the chemicals, bioactive compounds, and reagentswere obtained
from Sigma-Aldrich. Mouse monoclonal anti-FLAG (M2), rabbit poly-
clonal anti-FLAG, and rabbit polyclonal anti-calnexin were also pur-
chased from Sigma-Aldrich. Rabbit Anti-BiP was from abcam. Mouse
monoclonal anti-GPR34 used for ﬂuorescent imaging was from R&D
Systems. Rabbit polyclonal anti-GPR34 used for Western blotting was
from Abgent. Rabbit anti-GPP130 and rabbit anti-giantin were from
Covance. Mouse anti-Rho (clone 1D4) was obtained from Millipore.
Alexa Fluor®-488 and -594 conjugated secondary antibodies were pur-
chased from Life Technologies.
2.2. Expression constructs
A cDNA encoding the full-length human GPR34 (GenBank:
BC020678) was obtained from GE Dharmacon. By using commonly
used PCR-based methods, FLAG tag (DYKDDDDK) coding sequence
was fused in-frame either to the N terminus or the C terminus of
GPR34. For theN-terminal tagging, the FLAG tagwas placed immediate-
ly after the initiator methionine. For the C-terminal tagging, the tagwas
placed immediately before the stop codon. A full-length wildtype
GPR34 construct with the C-terminal Rho tag (TETSQVAPA) was also
created by using PCR based methods. Similarly, N-terminal truncationsand point mutations were introduced by widely used PCR-based tech-
niques. Recombinantly generated sequences were subcloned into
pcDNA5/TO mammalian expression vector (Life Technologies) using
BamHI and NotI restrictions sites. To test a surrogate design version of
GPR34 that has a cleavable signal sequence at its N terminus, human
GPR34 coding sequence was subcloned into KpnI and XbaI restriction
sites of pFLAG-CMV-3 expression vector (Sigma-Aldrich) so that the
GPR34 ORF is in-frame with the built-in rat trypsin signal and FLAG
tag located upstream of the multiple cloning sites. Because these two
restriction sites were located at the tail end of the multiple cloning
sites, a stretch of irrelevant 14 amino acids derived from the multiple
cloning sites sequence were inevitably incorporated to the ﬁnal coding
sequence; thus, the size appeared slightly larger in Western blotting.
To generate FLAG tagged N-tail domain constructs, the FLAG-
GPR34(1–61) region was PCR ampliﬁed from the FLAG-GPR34 tem-
plate. The N-terminal trypsin signal peptide and the C-terminal KDEL
sequence were added by using PCR-based methods. The PCR products
were then subcloned into pCIneo vector (Promega) using EcoRI and
NotI sites. All the DNA sequences were veriﬁed by Sanger method at
GENEWIZ, Inc.2.3. HEK293 cell culture and transient transfection
HEK293-EBNA1(6E) cells (hereafter HEK293 cells) were obtained
from National Research Council of Canada. HEK293 cells were cultured
in a humidiﬁed incubator (37 °C, 5% CO2) using FreeStyle™ F17
Expression Medium (Life Technologies). The cells were maintained in
suspension culture format in shaker ﬂasks (Corning) placed on an
Innova 2100 shaker platform (New Brunswick Scientiﬁc) rotating at
110 rpm. Expression constructs were transfected into HEK293
cells using the protocols described previously [22]. At 24 h post
transfection, cells were fed with Difco yeastolate (BD Biosciences). For
immunoﬂuorescent imaging, transfected cells were seeded onto a
poly-L-lysine coated glass coverslips in fresh cell culture media at 24 h
post transfection. The cells were then quiescently cultured for addition-
al 24 h before they were ﬁxed and stained (see below). For Western
blotting, transfected cells were harvested at 48 h post transfection
(see below).2.4. Immunoﬂuorescent microscopy
At 24 h post transfection, HEK293 cells (~600,000 cells per well)
were seeded onto poly-L-lysine coated glass coverslips placed in a 6-
well plate and quiescently incubated for 24 h in a fresh culture
media. The cells were ﬁxed in 100 mM sodium phosphate, pH 7.2,
containing 4% paraformaldehyde for 30 min at room temperature.
After washing steps in PBS containing 100 mM glycine, the ﬁxed
cells were placed in permeabilization buffer (PBS containing 0.4% sa-
ponin, 1% BSA, 5% ﬁsh gelatin) for 15min, followed by a staining with
designated primary antibodies for 60min at room temperature. After
repetitive washing in the permeabilization buffer, the cells were
then stained with Alexa Fluor-488 or -594 conjugated secondary an-
tibodies for another 60 min. After washes in permeabilization buffer,
coverslips were mounted onto glass slides using Vectashield mount-
ing media (Vector Laboratories). For the cell staining under non-
permeabilizing conditions, the blocking, staining and washing steps
were all carried out in PBS containing 1% BSA and 5% ﬁsh gelatin.
The slides were analyzed using a Nikon Eclipse 80i microscope
with 60× or 100× CFI Plan Apocromat oil objective lens and Chroma
FITC-HYQ or Texas Red-HYQ ﬁlter. Images were acquired with a Cool
SNAP HQ2 CCD camera (Photometrics) using Nikon Elements imag-
ing software. In a given set of experiments, images were taken by
using the same acquisition parameters for the cells expressing differ-
ent GPR34 mutant constructs.
1536 H. Hasegawa et al. / Biochimica et Biophysica Acta 1863 (2016) 1534–15512.5. Western blotting
At a desired time point after transfection, an aliquot of suspension
cell culture was removed from shake ﬂasks and the cell pellets were
harvested after a centrifugation step at 1000 g for 5 min. The cell pellets
were directly lysed in a lithiumdodecyl sulfate sample buffer (Life Tech-
nologies) containing 5% (v/v) beta-mercaptoethanol but without heat
treatments. To normalize the sample loading, whole cell lysates corre-
sponding to 12,000–12,500 cells were analyzed per lane. NuPAGE 4–
12% Bis-Tris gradient gel and the accompanying buffer system (all
from Life Technologies) were used to perform SDS-PAGE. Resolved pro-
teins were electrotransferred to a nitrocellulose membrane, blocked
with ﬂuorescent Western blocking buffer (Rockland Immunochemi-
cals), and probed with designated primary antibodies (see the legend
of individual ﬁgures). After multiple washes in PBS containing 0.05%
(v/v) Tween-20, the nitrocellulose membranes were probed with
Alexa Fluor-680 conjugated secondary antibody (Life Technologies).
The images of ﬂuorescent Western blot were acquired using an
Odyssey® infrared imaging system (LI-COR Biosciences).3. Results
3.1. Human GPR34 localizes to the cell surface in correct topology when
recombinantly expressed in HEK293 cells
Although GPR34 was ﬁrst cloned and characterized in 1999 [23,24],
its physiological functions are still poorly understood [25,26] and the
identity of cognate ligand remains controversial [27,28]. Despite its evo-
lutionary conservation in the last N450 million years of vertebrate
evolution [29], there are no known genetic variants or polymorphisms
that can suggest the functions of GPR34 [25,30]. The current study
was initiated to understand the biosynthetic steps of GPR34.
To detect recombinantly expressed GPR34, FLAG tag was fused
either to the N or C terminus of a full-length GPR34 coding sequence
(Fig. 1A, B). This epitope tagging becomes essential later because we
did not know a priori that the anti-GPR34 monoclonal antibody
(mAb) from R&D Systems that we used in this study recognizes a native
epitope that relies on a certain ‘conformational state’ of GPR34. The spe-
ciﬁc native epitope recognized by this mAb is referred to as the ‘mAb
epitope’ hereafter. Western blotting on the whole cell lysates revealed
a heterogeneous species of 60–70 kDa protein regardless of the position
of FLAG tag (Fig. 1C). The apparent sizewas larger than themass expect-
ed from the polypeptide sequence alone (44–45 kDa), which suggested
the presence of post-translational modiﬁcations. When the subcellular
localization was visualized by co-staining with anti-GPR34 and anti-
FLAG under permeabilizing conditions, the FLAG tagged GPR34was de-
tected predominantly on the plasma membrane of transfected HEK293
cells (Fig. 1D). The absence of marked accumulation in the early secre-
tory pathway compartments suggested that correct protein folding,
topogenesis and cell surface trafﬁcking were achieved at steady state
(Fig. 1D). Because the plasmamembrane localizationwas indistinguish-
able between ‘FLAG-GPR34’ and ‘GPR34-FLAG’ constructs, weFig. 1. Recombinantly expressed human GPR34 localizes to the plasma membrane of transfec
Protter tool [61] using the primary sequence and associated data obtained from UniProtKB un
Cys residues located in ECL1 and ECL2 (C127 and C204, respectively) are predicted to form a d
and C299 in ECL3 are not known. The predictable N-linked glycosylation sites are colored in p
ICL, intracellular loop. (B) A schematic representation of the wildtype human GPR34 constru
(C) Western blotting was carried out using the whole cell lysates prepared from the HEK2
nitrocellulose membrane was probed with rabbit anti-FLAG (polyclonal). Detected GPR34
marked by asterisk. (D) Fluorescent micrographs of HEK293 cells expressing N-terminally ta
were co-stained with mouse anti-GPR34 and rabbit anti-FLAG under membrane permeabi
micrographs of the same image ﬁeld are shown in the leftmost panels. (E, F) Fluorescent mic
cells were immunostained under permeabilizing conditions (ﬁrst row) or non-permeabilizin
and rabbit anti-GPP130. In panel F, the cells were co-stained with mouse anti-GPR34 and
permeabilization step. Images were captured by using identical acquisition settings.concluded that the location of FLAG tag did not have differential inﬂu-
ence on the biosynthetic steps or subcellular distribution of GPR34
(Fig. 1D).
To interrogate the membrane topology of recombinant GPR34 in
HEK293 cells, we examined whether the N-terminal FLAG epitope of
FLAG-GPR34 is accessible without membrane permeabilization steps.
The positive staining without saponin treatment demonstrated the ex-
tracellular localization of the N terminus (Fig. 1E, bottom). Although
the precise position and the biochemical properties remained elusive
at this point, the speciﬁc epitope recognized by the anti-GPR34 mAb
(i.e., the mAb epitope) was also accessible without membrane perme-
abilization (Fig. 1F, bottom). The immunostaining with anti-GPP130
was used here to monitor the membrane permeabilization status
(Fig. 1 E–F). In summary, human GPR34 readily exited from the ER
and trafﬁcked to the cell surface in correct topology in HEK293 cells.
3.2. Broadly conserved tri-basic motif located in the third intracellular loop
does not modulate GPR34 trafﬁcking
A tri-basic motif located in the third intracellular loop (ICL3) was
recently shown to function as a novel ER export signal in α2B adren-
ergic receptor [31] and a post-Golgi trafﬁckingmotif of β1 adrenergic
receptor [32]. Because this ICL3 tri-basic motif is widely conserved in
GPCRs and is present in GPR34 (Fig. 2A), we ﬁrst asked whether this
motif plays similar roles in GPR34 trafﬁcking. To this end, we exam-
ined the steady state subcellular distribution of GPR34 after revers-
ing the charge of ‘KRR’ ICL3 tri-basic motif into ‘EEE’ in one mutant
and neutralizing to ‘QQQ’ in another mutant (Fig. 2B). Unlike the
ﬁnding in adrenergic receptors [31,32], neither did the charge rever-
sal nor the charge neutralization have detectable effects on the cell
surface trafﬁcking or the steady state subcellular distribution
(Fig. 2C). Importantly, the speciﬁc mAb epitope remained detectable
in both mutants; thus, the gross topology of these mutants was most
likely unaffected (Fig. 2D and see below). An additional charge neu-
tralization mutant, in which KRR was replaced by AAA, did not show
any noticeable localization changes either (data not shown). In
agreement with the subcellular localization data, none of the ICL3
tri-basic motif mutants showed noticeable change in gel mobility,
suggesting negligible effects on the post-translational modiﬁcations
(Fig. 2E and see below). If the ICL3 tri-basic motif indeed functioned
as a trafﬁcking motif in GPR34, we expected that its elimination
would have produced detectable changes in subcellular distribution.
This ﬁnding illustrates that a conserved motif does not always play
the same roles in different GPCR context especially when a more
dominant signal is embedded elsewhere within the protein (see
below).
3.3. Mutations to the tri-basic motif located in the ﬁrst intracellular loop
result in Golgi retention and the loss of mAb epitope
GPR34 has another tri-basic motif ‘RKR’ in the ﬁrst intracellular
loop, or ICL1 (refer to Fig. 2A). The length of ICL1 is much shorter
than that of ICL3 and is predicted to be only 6- or 7-amino acidted HEK293 cells. (A) A snake plot topology model of human GPR34 generated with the
der Q9UPC5. Extracellular cysteine residues are colored in light green. Widely conserved
isulﬁde bond and are connected by a dotted green line. The redox status of C46 in N-tail
ink. A highly conserved ‘DRY’ motif in ICL2 is highlighted in red. ECL, extracellular loop.
cts with FLAG tag. The construct names are shown on the left. ORF, open reading frame.
93 cells transfected with FLAG-GPR34, GPR34-FLAG, or an empty vector (mock). The
proteins are marked by an arrowhead. Non-speciﬁcally detected protein of ~15 kDa is
gged FLAG-GPR34 (ﬁrst row) and C-terminally tagged GPR34-FLAG (second row). Cells
lizing conditions. Individual images were digitally overlaid in the ‘merge’ column. DIC
rographs of the HEK293 cells expressing N-terminally tagged FLAG-GPR34. Transfected
g conditions (second row). In panel E, cells were co-stained with mouse anti-FLAG (M2)
rabbit anti-GPP130. Both in E and F, GPP130 was not detected without the membrane
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synthesis and trafﬁcking, the RKR residues were mutated to EEE or
QQQ (Fig. 3A). In contrast to the ICL3 tri-basic motif mutants
(above), the charge reversal mutant ICL1(EEE) localized to a globularstructure that was populated by Golgi resident proteins such as
GPP130 (Fig. 3B, second row) and giantin (see below). This mutant
was apparently retained in the Golgi and had lost the capacity to traf-
ﬁc to the cell surface (Fig. 3B, second row). Similarly, the charge neu-
1538 H. Hasegawa et al. / Biochimica et Biophysica Acta 1863 (2016) 1534–1551tralization mutant ICL1(QQQ) accumulated in the Golgi and fre-
quently induced a round Golgi morphology (Fig. 3B, third row). The
loss of positive charge (and not the acquisition of opposite charge)
was hence sufﬁcient to impair some biosynthetic steps underlying
the cell surface trafﬁcking event. Although both mutants were still
readily detected by anti-FLAG (Fig. 3C, third column in red; and as
shown in above), the tri-basic motif mutants were no longer recog-
nized by the anti-GRP34 mAb (Fig. 3C, second column in green).
The mechanical relationships between the ICL1 tri-basic motif muta-
tions, the disappearance of mAb epitope, and the loss of cell surface
trafﬁcking competency are addressed in the sections below.
To preclude a possibility that the Golgi retention was induced by a
frameshifted or a prematurely terminated aberrant protein species,
we constructed the same pair of ICL1 tri-basic motif mutants with a C-
terminal FLAG tagwhere the detection by anti-FLAG assures the synthe-
sis of full-length proteins (Fig. 4A). Co-stainingwith anti-FLAG and anti-
GPP130 revealed that the Golgi-retention phenotypes were recapitulat-
ed in the C-terminal tag context (Fig. 4B). Furthermore, the C-terminal
FLAG versions also lost the native epitope recognized by the anti-
GPR34 mAb (data not shown). The lack of co-localization between the
globular structure and an ER marker BiP clearly showed the retention
was not in the ER (Fig. 4C). Lastly, co-transfection of ICL1 tri-basic mu-
tants and awildtype GPR34 constructwith the C-terminal Rho tag dem-
onstrated that the wildtype GPR34 could reach the cell surface in the
same cells that simultaneously expressed the ICL1 tri-basic mutants
(Fig. 4D). Therefore, the Golgi retention of ICL1 tri-basic mutants was
a cargo selective event and the mutant protein expression itself did
not cause general blockade of secretory pathway trafﬁcking. The same
results also indicated that co-expression of wildtype GPR34 could not
rescue ICL1 tri-basic mutants from Golgi retention.
Because the mAb epitope was already shown to reside somewhere
in the extracellular regions (see Fig. 1E), it was unlikely that the ICL1
tri-basic motif itself was the actual epitope for the anti-GPR34 mAb.
One possibility for why the loss of epitope and the loss of cell surface lo-
calization coincided was that this epitopewas a reporter for a particular
conformation or a folded state that was closely associated with cell sur-
face trafﬁcking competency or correct topology. The ICL1 tri-basic motif
mutation disrupted such normal conformational state; hence the epi-
tope was lost. At this stage, it was still unclear whether the epitope
was made of non-contiguous amino acid residues that come together
upon correct folding orwas composed of a topologically-sensitive linear
stretch of amino acid sequence, or even other possibilities.
Although the globular structures looked morphologically similar to
the Russell bodies induced by an accumulation of aggregated immuno-
globulins in the ER [22], the GPR34-positive structures were derived
from the Golgi compartments. In fact, when the cells were treated
with Brefeldin A, the ICL1 tri-basic mutants redistributed from the
Golgi to the ER (Fig. 5). The Brefeldin A-responsiveness underscored
the ﬂuidity and dynamic nature of the Golgi-retained mutants, as op-
posed to being terminally misfolded into insoluble protein aggregates.
Given that the mutants were allowed to exit the ER, the non-native
conformation induced by the tri-basic motif mutation was somehow
tolerated by the ER protein quality control mechanisms. The mutants
were instead retained by a poorly understood quality control system
operating in the Golgi compartment.
3.4. Placement of an exogenous signal sequence to the N terminus
overcomes the mislocalizing effects of ICL1 tri-basic motif mutations and
restores the cell surface trafﬁcking
Charge distribution in the ﬂanking regions of a transmembrane seg-
ment can play topogenic roles by inﬂuencing the orientation of trans-
membrane domain [33]. The more positively charged end of a
membrane-spanning segment is often retained in the cytosol, rather
than being translocated into the ER lumen [34]. As a result, lysines and
arginines are found more abundantly in the cytosolic ﬂanking areathan in the extracellular/lumenal edge of a transmembrane domain
(i.e., positive-inside rule) [35–37]. The sheer proximity of ICL1 tri-
basic motif to the ﬁrst transmembrane domain (TM1) led us postulate
that this tri-basic motif is a critical determinant that establishes the ori-
entation of TM1 via positive-inside rule. We also hypothesized that the
correct TM1 orientation is required for a folded state required for the
epitope generation and cell surface trafﬁcking. This model predicts
that the TM1 orients by keeping the positively charged ICL1 tri-basic
motif on the cytosolic side; which then allows the upstream N-tail to
translocate into the ER lumen post-translationally in a C to N direction
(Fig. 6A). This is similar to a process carried out by the ‘reverse signal-
anchor sequence’ of Type III transmembrane proteins [38]. Once the
TM1 sets correctly, the transmembrane segments that follow are co-
translationally integrated in alternate orientations until the 7th seg-
ment is embedded. In tri-basic mutants, by contrast, we propose that
the TM1 fails to orient correctly due to the loss of positively charged
cluster that otherwise provides a mechanical force to propel the N-tail
translocation. As a result, the TM1 is oppositely inserted, and the stretch
of amino acids preceding the TM1 remains in the cytosol (Fig. 6B). This
is a process similar to the action of ‘signal-anchor sequence’ in Type II
transmembrane proteins [38]. We surmise that oppositely oriented
TM1 hampers the rest of GPR34 topogenesis and induces incorrect
membrane topology that can no longer muster the mAb epitope and
facilitate the cell surface trafﬁcking.
In an effort to orient the TM1 segment correctly without the ICL1 tri-
basic motif, a cleavable signal peptide was placed directly upstream of
the N-terminal FLAG tag. The exogenously appended signal sequence
is expected to induce the co-translational translocation of the N-tail
into the ER lumen temporally ahead of the appearance of TM1 from
the ribosome (Fig. 6C). The signal sequence thereby has a potential
here to serve as an early-acting topology determinant that controls
the orientation of TM1, by bypassing the requirement for ICL1 tri-basic
motif. In this scenario, TM1 comes to serve as a ‘stop-transfer sequence’
that halts the N-tail translocation initiated by the signal sequence. To
test this model, we produced a set of GPR34 constructs that have a sig-
nal sequence of rat trypsin fused directly upstream of the N-terminal
FLAG tag (Fig. 7A). Themutant constructs were testedwhether this sur-
rogate design rescues the tri-basic motif mutants from Golgi arrest. The
artiﬁcial construct design itself showed negligible disruptive effects on
the topogenesis and trafﬁcking when the wildtype GPR34 was tested
in [Signal]::FLAG-GPR34 context (Fig. 7A; B, ﬁrst row). In the context
of ICL1 tri-basic motif mutants (depicted in Fig. 7A, second row), the
N-terminally placed cleavable signal sequence suppressed the
mislocalizing effects of the mutations; and reinstated the cell surface
trafﬁcking capacity (Fig. 7B, second to ﬁfth rows). The results supported
the critical importance of TM1 orientation in determining the fate of
GPR34 topogenesis and subcellular localization. The topogenic require-
ment for the ICL1 tri-basic motif was bypassed by inducing a co-
translational ER translocation of the N-tail domain.
3.5. The mAb epitope and post-translational modiﬁcations are restored
when the TM1 orientation is rectiﬁed by the signal sequence addition
In response to the reinstatement of cell surface trafﬁcking by the sig-
nal peptide-based surrogate design, the lost mAb epitope was also re-
stored in the tri-basic motif mutants (Fig. 8A, green). The rescue of
TM1 orientation clearly led to the reestablishment of the mAb epitope
and cell surface trafﬁcking capacity in ICL1 tri-basic motif mutants.
If the N-tail and the extracellular loops end up in the wrong side of
the membrane, the expected post-translational modiﬁcations may not
take place. For that matter, the mutants may become susceptible to un-
expected post-translational processing in return. Although the precise
numbers and the types of post-translational modiﬁcations are not
known in GPR34, if the topology disruption does occur, such change
may become detectable in the form of altered protein mobility in SDS-
PAGE. Likewise, if the artiﬁcial signal peptide design indeed rectiﬁes
Fig. 2.Mutations to the ICL3 tri-basic motif do not alter steady state subcellular distribution of GPR34. (A) Positively charged resides are colored in blue in this topology model. Tri-basic
motifs located in ICL1 and ICL3 aremarked by bold blue lines. (B) A schematic diagram showing that ‘KRR’ tri-basic motif in ICL3 is mutated to ‘EEE’ or ‘QQQ’ to achieve charge reversal or
neutralization effects. (C, D) Fluorescent micrographs of the HEK293 cells expressing ICL3(EEE) mutant (ﬁrst row) or ICL3(QQQ) mutant (second row). Transfected cells were
immunostained under permeabilizing conditions. In panel C, cells were co-stained with mouse anti-FLAG (M2) and rabbit anti-GPP130. In panel D, cells were co-stained with mouse
anti-GPR34 and rabbit anti-calnexin. Unlabeled scale bars in panel D represent 10 μm. (E) Western blotting on the whole cell lysates prepared from the HEK293 cells expressing
wildtype FLAG-GPR34 (lane 1), three different ICL3 tri-basic motif mutants (lanes 2–4), and empty vector (mock, lane 5). The nitrocellulose membrane was probed with rabbit anti-
FLAG (polyclonal). Detected GPR34 proteins were marked by an arrowhead. Non-speciﬁcally detected ~15 kDa protein is marked by asterisk.
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mutants, their post-translational modiﬁcations should be restored to
those of the wildtype GPR34.
To test whether there are detectable gel mobility differences be-
tween the wildtype, tri-basic mutants, and the tri-basic mutants
corrected by signal sequence, we examined their protein gel mobility
by Western blotting. For the N-terminal FLAG versions, the wildtype
construct ran as heterogeneous 60–70 kDa proteins (Fig. 8B, lane 1,
probed with anti-FLAG; Fig. 8C, lane 4, probed with polyclonal anti-
GPR34). The ICL1(EEE) mutant showed a protein band of ~30 kDa and
some higher molecular weight smeary signals (Fig. 8B, lane 2; Fig. 8C,
lane 5). The size reduction to ~30 kDa can be explained by the loss of
major post-translational modiﬁcations or an unexpected acquisition of
proteolytic susceptibility or both. The smeary signalwas perhaps caused
by an increased aggregation propensity of themutant or by a prominent
poly-ubiquitination event. Although ICL1(QQQ) mutant behaved simi-
larly to ICL1(EEE) mutant in terms of subcellular localization, its West-
ern blotting signal was below detection (Fig. 8B, lane 3; Fig. 8C, lane
6). The undetectably low signal in the whole cell lysate was caused by
a rapid loss of protein expression in the majority of transfected cells,
rather than poor transfection efﬁciency. For the C-terminal FLAG conﬁg-
uration, the wildtype was again at 60–70 kDa (Fig. 8B, lane 4; Fig. 8C,
lane 7) and the ICL1(EEE) mutant was found as a 30 kDa band and
high molecular weight species (Fig. 8B, lane 5; Fig. 8C, lane 8). The C-
terminal FLAG version of ICL1(QQQ)mutantwas again difﬁcult to detect
for the same reasons as above (Fig. 8B, lane 6; Fig. 8C, lane 9). Subse-
quently, we found that ICL1(QQQ) mutant proteins become faintly
detectable by Western blotting after a prolonged treatment with pro-
teasome inhibitor MG-132. Under this condition, the detected protein
was ~30 kDa and was similar to the major band of ICL1(EEE) mutants
(data not shown).
The signal sequence versions appeared as 65–75 kDaproteins for the
wildtype, ICL1(EEE) mutant, and ICL1(QQQ) mutant (Fig. 8B, lanes8–10; Fig. 8C, lanes 1–3). A slightly larger size for the signal sequence
versionswas due to an inevitable inclusion of extra amino acids derived
from a multiple cloning site located downstream of the vector-encoded
FLAG tag (see Materials and methods). In agreement with the restored
trafﬁcking and mAb epitope, no major differences were detectable be-
tween them except that ICL1(EEE) version had a secondary band at
~50 kDa and the ICL1(QQQ) mutant had ~50% less amount of speciﬁc
protein at steady state (Fig. 8B, lanes 8–10; Fig. 8C, lanes 1–3). In sum-
mary, although the precise biochemical reasons of the gel mobility dif-
ferences remain elusive, the altered gel mobility patterns in the
mutants were all restored to those of the wildtype by simply adding
an exogenous signal sequence to the N terminus as a surrogate
topogenic signal.
3.6. Progressive truncation of the N-tail domain perturbs the mAb epitope
and cell surface trafﬁcking
To ask whether the intact ICL1 tri-basic motif is sufﬁcient for the
normal protein topogenesis, we progressively truncated the extra-
cellular N-tail consisting of 61 amino acids (Fig. 9A). Deletion of the
ﬁrst 17 and 34 residues did not disturb the mAb epitope or the cell
surface trafﬁcking (Fig. 9B, ﬁrst two rows). A further truncation (as
in NTΔ48 mutant) resulted in the loss of mAb epitope (Fig. 9B,
third row, second column). Co-staining with anti-FLAG revealed
that the NTΔ48mutant was fully synthesized but retained intracellu-
larly, and did not progress beyond the Golgi compartment (Fig. 9B,
third row, third column). The NTΔ61 mutant behaved similarly to
that of NTΔ48 mutant (Fig. 9B, bottom row). It was not clear from
this result alone whether the lack of cell surface trafﬁcking was
caused by the loss of speciﬁc determinant or simply by a loss of con-
formational integrity. However, by judging from the disappearance
of two key characteristics (i.e., the mAb epitope and the cell surface
trafﬁcking), the short region of residues 35–47 may code for key
Fig. 3. Charge neutralization of the ICL1 tri-basic motif is sufﬁcient to prevent the cell surface trafﬁcking of GPR34. (A) A schematic diagram showing the ‘RKR’ tri-basic motif in ICL1 is
mutated to ‘EEE’ and ‘QQQ’ in order to achieve charge reversal and neutralization effects, respectively. The mutations were introduced to the N-terminally FLAG tagged construct. (B,
C) HEK293 cells expressing FLAG-GPR34 wildtype (top row), ICL1(EEE) mutant (second row), and ICL1(QQQ) mutant (third row). Transfected cells were immunostained under
permeabilizing conditions. Panel B, co-staining with mouse anti-FLAG (M2) and rabbit anti-GPP130. Panel C, co-staining with mouse anti-GPR34 and rabbit anti-FLAG (polyclonal).
Both ICL1(EEE) and ICL1(QQQ) mutants were no longer recognized by the mouse anti-GPR34 mAb. Images were taken by using the same acquisition parameters.
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mAb epitope and cell surface trafﬁcking competency.
3.7. The mAb epitope formation and the cell surface trafﬁcking are
separable
We expected that structural features embedded in the short re-
gion of residues 35–47 would provide additional clues to understand
GPR34 topogenesis and trafﬁcking. A closer look into this region re-
vealed three distinct sequence-based characteristics. First is the
three N-linked glycosylation motifs at positions 28, 36, and 42. Sec-
ond is a proline-rich segment where four prolines are located at 33,
34, 41, and 47. Third is the presence of a seemingly unpaired cysteine
residue at 46. To examine these characteristics individually, the cor-
responding amino acids were mutated to alanine as illustrated inFig. 10A and the resulting mutants were tested for the presence of
mAb epitope and their subcellular localization. Whereas the gel mo-
bility of ‘Proline-rich’ and ‘C46A’ mutants remained roughly the
same as that of wildtype GPR34-FLAG (Fig. 10B, lanes 1, 3, 4), a
marked size reduction ensued for ‘N-glycans’ mutant (Fig. 10B, lane
2). The size decrease was most likely caused by the loss of N-linked
glycans at mutated sites. One of the minor bands at ~30 kDa was
identical in size to the protein detected in ICL1(EEE) mutant (see
Fig. 8B, lanes 2 and 5).
Unlike the trafﬁcking defects produced by the NTΔ48 mutant, the
cell surface trafﬁcking of the three mutants was not compromised
(Fig. 10C). One way to reconcile this result with that of NTΔ48 mutant
is that the Golgi-retention of the NTΔ48 mutant was caused largely by
a reduced structural integrity or due to a deletion of unknown post-
Golgi trafﬁcking signals.
Fig. 4. Golgi retention of ICL1 tri-basic motif mutants is not caused by a prematurely terminated or a frameshifted GPR34 species. (A) A schematic illustration of ICL1 tri-basic motif
mutants. In this construct set, the ICL1 tri-basic motif was mutated to ‘EEE’ or ‘QQQ’ in the C-terminal FLAG tag context. (B) HEK293 cells expressing ICL1(EEE) mutant (ﬁrst row) and
ICL1(QQQ) mutant (second row). Transfected cells were immunostained under permeabilizing conditions using mouse anti-FLAG (M2) and rabbit anti-GPP130. (C) HEK293 cells
expressing ICL1(EEE) mutant were co-stained with mouse anti-FLAG (M2) and rabbit anti-BiP. (D) Fluorescent images of a population of HEK293 cells co-transfected with wildtype
GPR34-Rho and ICL1 tri-basic mutants with C-terminal FLAG tag. Cells were co-stained with mouse anti-Rho (clone 1D4) in green and rabbit anti-FLAG (polyclonal) in red. Unlabeled
scale bars represent 10 μm.
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tency, it was expected that all threemutants display themAb epitope be-
cause their trafﬁcking was undisrupted. Interestingly, however, the state
of mAb epitope varied depending on the introduced mutations. The N-
glycan mutant retained the mAb epitope as evident from the positive
anti-GPR34 staining (Fig. 10D, ﬁrst row). By contrast, anti-GPR34 mAb
could no longer recognize the ‘Proline-rich’ and C46A mutants even
though both mutants trafﬁcked to the cell surface (Fig. 10D, second and
third rows). The mAb epitope formation can therefore be uncoupled
from the cell surface trafﬁcking competency by a set of point mutations
in the N-tail domain. Instead of being a requirement for the cell surface
trafﬁcking, the mAb epitope formation and the cell surface trafﬁcking
turned out to be two separate events of the GPR34 biosynthesis.3.8. ER translocation of the N-tail domain is not sufﬁcient to generate the
mAb epitope
Because the mAb epitope was abrogated by a targeted mutagenesis
within a short region of the N-tail, we ﬁrst favored the epitope being con-
sist of a linear sequence at Cys-46 and the adjacent proline residues. One
possibility for a contiguous stretch of amino acids to show topologically-
sensitive characteristics are that the epitope is established onlywhen this
short motif is translocated into the ER lumen by the action of correctly
oriented TM1. This model predicts that the intact N-tail by itself does
not instantly become the epitope unless the N-tail domain translocates
into the ER lumen where ER resident enzymes such as oxidoreductases
and peptidyl-prolyl isomerases are present. If the orientation of TM1 is
Fig. 5.Golgi-retained ICL1 tri-basicmutants redistribute to the ER uponBrefeldinA treatment. Fluorescentmicrographs ofHEK293 cells expressing the FLAG-ICL1(EEE) construct (ﬁrst two
rows) and the ICL1(EEE)-FLAG construct (third and fourth rows) under steady state conditions or after a Brefeldin A (BFA) treatment for 1 h at 15 μg/ml. Cells were co-stainedwithmouse
anti-FLAG and rabbit anti-giantin under membrane permeabilizing conditions. Scale bars, 10 μm.
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sequencewould be facing the cytosol instead, and this prevents theN-tail
sequence from ‘maturing’ into themAb epitope. Although detailed phys-
icochemical properties of the epitope remain elusive, this testable model
offers a potential explanation for why the mAb epitope was lost in ICL1
tri-basic motif mutants—due to the TM1 inversion—and restored by
adding the cleavable N-terminal signal peptide.
If the epitope is made of a stretch of sequence fully contained within
theN-tail domain, the ER translocation of an isolatedN-tail domain is suf-
ﬁcient to generate the epitope. If the epitope formation requires a distant-
ly located amino acid sequence that must come together upon correct
topogenesis and folding, the ER translocation of the isolated N-tail is not
sufﬁcient to give rise to the mAb epitope. To differentiate these two pos-
sibilities, we created a pair of N-tail constructs consisting of the ﬁrst 61
residues of GPR34 with the N-terminal FLAG tag. The ﬁrst is a plain N-
tail domain construct that is expected to reside in the cytosol because
of the absence of subcellular targeting signals (Fig. 11A, top). The second
is destined for ER translocation and ER retention by virtue of the N-
terminal cleavable signal sequence and the C-terminal KDEL motif
(Fig. 11A, bottom).We found that the isolated N-tail domainwas difﬁcult
to overexpress in the cytosolic compartment duemost likely to a fast pro-
tein turnover. As a result, the cytosolic N-tail constructwas not detectable
by using anti-FLAG or anti-GPR34 (Fig. 11B, top). By contrast, the process
of ER translocation protected the N-tail construct from a rapid degrada-
tion and, accordingly, the ER-resident version was readily detected by
anti-FLAG staining (Fig. 11B, second and third rows, red). However, the
same N-tail domain construct failed to display the mAb epitope
(Fig. 11B, second and third rows, center column). The results supported
that the translocation of an isolated N-tail domain alone was not sufﬁ-
cient to generate the topologically sensitive epitope. This ﬁnding alluded
to the presence of amino acid sequences located outside of the N-tail do-
main that participate in the epitope formation.
3.9. All four cysteine residues in four separate extracellular domains are
required to produce a reductant-labile mAb epitope
There are total of four cysteine residues in the extracellular regions
of GPR34 (see Fig. 1A). Cys-46 in the N-tail was characterized in oneof the previous sections andwas found to play roles in themAb epitope
formation; yet, its redox status is still unclear. The positions of ECL1 Cys-
127 and ECL2 Cys-204 are conserved among GPCRs and they generally
form a disulﬁde bridge [39–41].Whether these two cysteines form a di-
sulﬁde bridge in GPR34 is unknown. The redox status of Cys-299 located
in ECL3 is not known either. To askwhich of the cysteines in three extra-
cellular loops (i.e., Cys-127, Cys-204, Cys-299) are important for the epi-
tope generation, we created a set of point mutants by substituting
individual cysteines with serines (see Fig. 12A). The effects of themuta-
tion on protein expression, localization, and epitope formation were
tested as before.Western blotting revealed that all three Cys-to-Sermu-
tants acquired designated post-translational modiﬁcations and ran as
the expected 60–70 kDa protein (Fig. 12B, lanes 3–5), which was
undistinguishable from the wildtype and C46A mutant (Fig. 12B, lanes
1–2). Imaging study showed that all three mutants reached the cell sur-
face, but none of themdisplayed the epitope (Fig. 12C). By taking the re-
sults of C46A mutant and these three mutants into account, all four
cysteine residues in the extracellular regions were required to produce
themAb epitope. Missing any one of the four cysteines was sufﬁcient to
prevent the epitope formation. Importantly, having the odd numbers of
extracellular cysteines did notmake thesemutants the substrates of free
thiol-mediated ER retention mechanisms.
To determine the relationship between the redox status of extracel-
lular cysteines and the epitope,we examined the integrity of the confor-
mational epitope before and after treating the transfected cells with a
cell-impermeable chemical reductant TCEP. Before the reductant treat-
ment, the wildtype FLAG-GPR34 was detected on the cell surface by
both anti-GPR34 and anti-FLAG, as expected (Fig. 12D, top). After
TCEP treatments, themAb epitope directly accessible from the extracel-
lular space was selectively abolished, but the FLAG-GPR34 protein itself
was still detectable on the cell surface if we used anti-FLAG for detection
(Fig. 12D, second and third rows). A fraction of FLAG-GPR34 protein that
still localized intracellularly withstood the reduction, and the mAb epi-
tope was still detectable in those intracellular species (Fig. 12D, second
and third rows, arrowheads). Collectively, the mutagenesis and the
sensitivity to reductant treatment showed that all four extracellular cys-
teines were in the oxidized state, and the oxidation of cysteine residues
was essential for the epitope generation process.
Fig. 6. Themodels of transmembrane domain orientation in different construct design. (A) Under normal wildtype settings, the N-terminal extracellular domain is fully synthesized in the
cytosol before the appearance of TM1 segment from the ribosome (a). TM1directs the ‘nascent chain-ribosome-mRNA’ complex to a translocon channel (a). By virtue of thepositive-inside
rule that effects through the ICL1 tri-basic motif, the TM1 segment orients in a manner similar to the ‘reverse signal anchor sequence’ of Type III membrane proteins (b). Driven by a
mechanical force generated by the correctly oriented TM1, the N-terminal region that precedes the TM1 then translocates into the ER lumen post-translationally in a C to N direction
through the translocon (b, c, d). After the correct insertion of TM1, the transmembrane segments that follow are integrated to the ER membrane co-translationally in alternate
orientations (e). (B) The ICL1 tri-basic motif mutants follow the same process until the TM1 segment emerges from the ribosome and getting targeted to a translocon (a). Due to the
lack of tri-basic motif, the TM1 interacts with translocon without a strong commitment to orient in one direction. It is energetically unfavorable to translocate the entire N-tail region
into the ER lumen post-translationally without the aid of tri-basic motif. The TM1 fails to orient correctly and is inserted to the ER membrane in the opposite orientation due to the
lack of motive force generated by the TM1 orientation events (b). This process is similar to those of the ‘signal-anchor sequence’ of Type II membrane proteins. As a result, the stretch
of amino acids preceding the TM1 remains in the cytosol (c, d, e). (C) If a signal sequence is present at the N terminus, co-translational translocation of the N-tail region is initiated
into the ER lumen and completes before the appearance of TM1 segment. In this new situation, TM1 serves as a ‘stop-transfer sequence’ similar to those of Type I membrane proteins
(a, b, c). Then a signal peptide is cleaved to release a new N terminus (N′) into the ER lumen (d). Although the mechanism is different from the wildtype GPR34, this mode of
membrane insertion can result in the correct TM1 orientation even without the tri-basic motif mediated mechanisms (e, f).
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4.1. Integration of topogenesis and cell surface trafﬁcking by positive-inside
rule
Protein folding, topogenesis and intracellular trafﬁcking of GPCRs
are interrelated biosynthetic events that must be carefully coordinated
to ensure a protein delivery to the cell surface. How these events are
orchestrated has not been well understood. Given that GPCRs are such
diverse groups of proteins, biosynthetic processes are likely to be
tailored to meet individual GPCRs' functional needs and their
physicochemical characteristics embedded in the primary sequence
and the folded three-dimensional structure. To elucidate the biosyn-
thetic strategies adopted by individual GPCRs, we investigated thedeterminants of membrane topology and how they relate to the acqui-
sition of cell surface trafﬁcking competency by using human GPR34 as
our model cargo.
Our ﬁndings supported the central importance of TM1 orienta-
tion in GPR34 topogenesis. While there are multiple ways to insert
the TM1 to membrane, GPR34 achieved this task by a process driven
by the classical positive-inside rule in which the tri-basic motif in
ICL1 played central roles. In some bacterial polytopic membrane pro-
teins, for instance, the orientation of upstream TM segments remain
ﬂexible (or reversible) and the topogenic signals in downstream re-
gions can retroactively inﬂuence the upstream TM orientation [42,
43]. Unlike those examples, the gross topology of GPR34 was severe-
ly disrupted by mutating the ICL1 tri-basic motif. In GPR34, no
downstream signals can correct the topogenic errors incurred by
1544 H. Hasegawa et al. / Biochimica et Biophysica Acta 1863 (2016) 1534–1551the loss of ICL1 tri-basic motif. We therefore argue that the topogenic
signals of GPR34 are heavily front-loaded and the fate of receptor
biosynthesis can be determined as soon as the orientation of TM1 is
set in place.
This study revealed that a tri-basic motif located immediately
downstream of the critical TM1 segment was responsible for
establishing the orientation of TM1, and the rest of GPR34 topology.
The correct topogenesis, in return, was required for acquiring cell
surface trafﬁcking competency. Thus, instead of having two separate
mechanisms (or determinants) for topogenesis and trafﬁcking inde-
pendently, GPR34 uses a uniﬁed economical mechanism that simul-
taneously regulates both steps by a simple charge-based motif. From
a different point of view, relying on a single motif for multiple as-
pects of GPCR biosynthesis has a risk. If something goes wrong in
this key biosynthetic step, it is very difﬁcult to undo the error be-
cause there are no corrective mechanisms embedded in the down-
stream segments of GPR34 protein. The short length of the ICL1 and
the cluster of three consecutive positive-charge residues simply il-
lustrate a strong selection pressure toward ensuring this critical
topogenic step to be a fail-proof process.Fig. 7. Placement of an exogenous signal sequence to the N terminus overcomes the mislocali
FLAG-GPR34 construct with an exogenous signal sequence fused to the N terminus (ﬁrst row
second row. Construct nomenclature is shown on the left. The spacing between the FLAG an
sites (MCS). See ‘Materials and methods’ for detail. (B) HEK293 cells expressing [Signal]::F
[Signal]::FLAG-ICL1(QQQ) mutant (bottom two rows). Transfected cells were immunostained4.2. Biochemical rationales behind the topological and conformational na-
ture of the epitope
The ﬁrst step to generate the topologically-sensitive conformational
epitopewas the translocation of N- tail into the ER lumen. If the TM1ori-
entation was inverted by the ICL1 tri-basic motif mutations, the N-tail
segment could not contribute to the epitope formation process. Like-
wise, if the N-tail was truncated, the epitope was not generated.
Speciﬁcally, the Cys-46 and the adjacent proline-rich segment
were both required for the epitope formation, but the ER transloca-
tion of N-tail domain alone was still insufﬁcient to generate the
epitope. In fact, the epitope-forming elements were not fully
contained within the N-tail region. Three additional extracellular
cysteines (namely, Cys-127 in ECL1, Cys-204 in ECL2, and Cys-299
in ECL3) were indispensable for the epitope formation because mu-
tation in any one of the cysteine residues effectively obliterated the
epitope. The biochemical properties of the mAb epitope and the
redox state of the four extracellular cysteines became clear when
the epitope was found to be sensitive to chemical reductant treat-
ment. Although the oxidized state of cysteine residues werezation effects of tri-basic motif mutations. (A) Schematic representations of the wildtype
). Tri-basic motif mutants in the signal sequence construct design are illustrated in the
d GPR34 indicates a stretch of amino acids derived from the unutilized multiple cloning
LAG-GPR34 (top row), [Signal]::FLAG-ICL1(EEE) mutant (second and third rows), and
under permeabilizing conditions using mouse anti-FLAG (M2) and rabbit anti-GPP130.
Fig. 8.Restoration of cell surface trafﬁcking competency coincideswith the reinstatement ofmAb epitope and post-translationalmodiﬁcations. (A)Micrographs of HEK293 cells expressing
[Signal]::FLAG-GPR34 (top row), [Signal]::FLAG-ICL1(EEE) mutant (second and third rows), and [Signal]::FLAG-ICL1(QQQ) mutant (forth row). Transfected cells were immunostained
under permeabilizing conditions using mouse anti-GPR34 and rabbit anti-FLAG (polyclonal). (B) Western blotting results for the wildtype (WT) GPR34, ICL1(EEE), and ICL1(QQQ) in
three different construct designs. Lanes 1–3 are in the FLAG-GPR34 context. Lanes 4–6 are in the GPR34-FLAG context. Lanes 8–10 are in the signal sequence-based molecular design.
Whole cell lysates prepared from transfected HEK293 cells were resolved by SDS-PAGE and probed with rabbit anti-FLAG (polyclonal). Different versions of GPR34 proteins were
marked by bracket symbols shown on the right. Non-speciﬁc protein of ~15 kDa is marked by asterisk. (C) The same set of whole cell lysates shown in panel B were probed with
rabbit anti-GPR34. Sample names are shown at the top of each lane. Note: The order of sample loading in panel C is slightly different from the gel shown in the panel B.
1545H. Hasegawa et al. / Biochimica et Biophysica Acta 1863 (2016) 1534–1551required for the epitope formation, the physical evidence is still
lacking whether the oxidation of four cysteines involves two pairs
of disulﬁde bridges or other forms of oxidation reactions such as
cysteinylation or glutathionylation. Crystallographic and mass
spectrometric analyses will be able to provide the deﬁnitive an-
swers to the disulﬁde connectivity and the physicochemical identi-
ty of the epitope.
Requirement for the distantly located residues to come together
makes this a conformationally sensitive epitope. The fact that cysteine
oxidation is to take place in the ER lumen makes this a topologicallysensitive epitope, too. If the GPR34 topologywas partially or completely
disrupted, the distantly located epitope-forming residuesmay not come
close enough, they may end up separated in the opposite sides of the
membrane, or they can all end up in the wrong side of the membrane.
In the ICL1 tri-basic motif mutants, the N-tail domain was most likely
ﬂipped to the cytosolic side. In this case, the amino acid sequences sim-
ply could not ‘mature’ into the mAb epitope because the N-tail was not
exposed to the environment of the ER lumen. By placing the signal se-
quence as the upstream topogenic element, the orientation of TM1
was corrected and the N-tail and the designated extracellular loops
Fig. 9. Progressive truncation of the N-terminal extracellular tail abrogates the cell surface trafﬁcking and the mAb epitope. (A) Schematics of mutant constructs with progressive
truncations from the N terminus. Mutants were constructed using GPR34-FLAG as template. The ﬁrst 17 amino acids are deleted in mutant NTΔ17. Likewise, corresponding number of
resides was truncated in NTΔ34, NTΔ48, and NTΔ61 mutants. In all settings, the initiation methionine (shown in bold lettering) was placed in the framework of a canonical Kozak
sequence. (B) HEK293 cells expressing individual truncation mutants were co-stained with mouse anti-GPR34 and rabbit anti-FLAG (polyclonal). The construct name is shown on the
left of each row. Images were captured by using identical acquisition parameters.
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were able to ‘mature’ into the recognizable mAb epitope.
Even when all four extracellular cysteines were intact, disruption of
the proline-rich segment alone was sufﬁcient to obliterate the mAb
epitope. How can the proline-rich segment contribute to the epitope for-
mation or inﬂuence the cysteine oxidation?We speculate that these pro-
line residues are the substrate for peptidyl-prolyl cis-trans isomerases
such as cyclophilins; and the isomerization status of the prolines play
roles in epitope generation by inﬂuencing the readiness of disulﬁde
bridge formation between Cys-46 and the cognate cysteine partner
(most likely Cys-299). It is interesting to note that cyclophilins were
shown to play critical roles in rhodopsin biosynthesis [5] and functions
[44].
N-glycans added to the extracellular domain can sometimes func-
tion as a ratchet mechanism that prevents the extracellular region
from sliding back to the cytosol. This mechanism helps the extracellular
domain to be irreversibly locked in place in somemembrane-anchored
proteins [45]. Just like many other GPCRs with no signal peptide,
GPR34’s N-tail translocates into the ER lumen post-translationally in aC to N direction after the TM1 orients correctly. Therefore, this type of
N-glycan based ratchet mechanism does not suit the need of GPR34
and many other GPCRs. In fact, the removal of three N-glycosylation
motifs from the GPR34N-tail did not affect the topogenesis and trafﬁck-
ing. The roles of two additional N-glycosylation motifs at 200 (in ECL2)
and at 295 (in ECL3) were not examined in this study.
As a side note, the existence of a chemically labile and
topologically-sensitive conformational epitope may signify the difﬁ-
culties of raising therapeutic mAbs against the extracellular regions
of GPCRs [46]. Because researchers tend to use an isolated N-tail
domain expressed in E.coli or chemically synthesized extracellular
loop peptides as immunogens, the employed immunogens cannot
display conformationally sensitive epitopes that are encoded by
non-contiguous amino acid residues or epitopes in which post-
translational modiﬁcations play roles. The mAb epitope described
in this study was topologically-sensitive because its formation
required the biochemical environment of the ER lumen; and
conformationally sensitive because distantly located sequences
needed to be brought together by correct folding and topogenesis.
Fig. 10. Uncoupling of the mAb epitope from the cell surface trafﬁcking by point mutations. (A) Diagrams of point mutations introduced to the N-terminal extracellular region
around residues 27–47. ‘N-glycans’ mutant has N-to-A mutations at three N-linked glycosylation motifs located at 28, 36, and 42. ‘Proline-rich’ mutant has P-to-A mutations at
four proline residues at 33, 34, 41, and 47. ‘C46A’ mutant has a C-to-A mutation at position 46. (B) Western blotting results for the wildtype GPR34-FLAG (lane 1) and the three
mutants (lanes 2–4).Whole cell lysates were prepared from the transfected HEK293 cells. The lysates were resolved by SDS-PAGE and probedwith rabbit anti-FLAG (polyclonal).
(C) HEK293 cells expressing different mutant constructs were co-stained with mouse anti-FLAG (M2) and rabbit anti-GPP130. The mutant construct name is shown on the left of
each row. (D) HEK293 cells transfected with the mutant constructs were co-stained with mouse anti-GPR34 and rabbit anti-FLAG (polyclonal). Images were captured by using
identical acquisition settings.
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Fig. 11. ER translocation of an isolated N-tail domain is not sufﬁcient for the mAb epitope formation. (A) A diagram of GPR34(1–61) N-tail constructs. The isolated N-tail region was N-
terminally FLAG tagged. Absence of targeting signals in FLAG-GPR34(1–61) makes this construct to stay in the cytosolic compartment after the synthesis (top row). Addition of the
exogenous rat trypsin signal sequence induces the ER translocation of FLAG-GPR34(1–61) construct, while the addition C-terminal KDEL motif retains the N-tail domain construct in
the ER (second row). (B) Transfected HEK293 cells expressing the N-tail constructs. Cells were co-stained with mouse anti-GPR34 and rabbit anti-FLAG (polyclonal). The mutant
construct name is shown on the left. The plain N-tail construct was not even detectable using anti-FLAG. Unlabeled scale bars represent 10 μm.
1548 H. Hasegawa et al. / Biochimica et Biophysica Acta 1863 (2016) 1534–1551The work presented here can serve as a model case when assessing
the strategies to raise antibodies against the extracellular regions of
GPCRs and other polytopic membrane proteins such as transporters
and ion channels.4.3. Protein quality control mechanisms in the Golgi compartment
Although the ER is regarded as the central protein quality compart-
ment for secretory and membrane-anchored proteins, the presence of
post-ER quality control mechanisms has been suggested [47,48].
Whether theGolgi can serve as such compartment has yet to be fully de-
termined. As far as the Golgi retention is concerned, the mechanisms
were studied by using Golgi resident membrane-anchored proteins
such as glycosyltransferases and glycosidases [49] or viral glycoproteins
[50]. When it comes to the quality control-based Golgi retention of mu-
tant GPCRs, the processes and themolecular components are still large-
ly unknown [51]. We presented that the trafﬁcking of ICL1 tri-basic
motif mutants was arrested at the Golgi compartment due to protein
quality problems induced most likely by the inversion of TM1 orienta-
tion. Evidently, certain quality attributeswere not part of the ER surveil-
lance repertoire because the tri-basic mutants were allowed to exit the
ER despite the defects. Understanding what speciﬁc attributes are
monitored in different systems would be the initial step for elucidating
how the Golgi quality control systems operate and how it differs from
the ER mechanisms.
Another poorly-understood area of interest would be the fate of
membrane-anchored proteins retained in the Golgi due to quality
control reasons and how those proteins are disposed. One possibility
is they are sent back to the ER via retrograde transport and subjected
to the ERAD. Another obvious possibility would be that they are
sorted to lysosomal pathways for degradation, similar to what was
shown for a yeast protein Wsc1p [48] and mutant prion proteins
[52]. Yet another possibility would be they remained enclosed in
the Golgi membrane and create a long-lasting compartment similar
to that of ER-derived Russell body found in immunoglobulin ex-
pressing cells [22]. Whether the accumulation of mutant GPR34 in
the Golgi would elicit Golgi stress response [53] is currently un-
known. The ICL1 tri-basic motif mutants identiﬁed in this studymay be a suitable cargo protein in interrogating the details of such
poorly-understood signaling pathway.4.4. Diverse roles of tri-basic motifs in different aspects of membrane-
anchored protein biosynthesis
We are curious to know how many proteins in the GPCR family do
possess ICL1 tri-basicmotif andwhat it does in a different GPCR context.
The ICL1 tri-basic motif is conserved in GPR34 of diverse species [29].
Related family members such as P2Y12, P2Y13, P2Y14, GPR82, GPR87
and GPR171, however, do not have the ICL1 tri-basic motif although
many of them possess the ICL3 tri-basic motif. A brief survey on a
small number of GPCRs revealed that the ICL1 tri-basic motif is present
in GPR183 in the form of ‘RKK’ (UniProtKB: P32249) and in GPR107 as a
more extensive ‘RKRR’ motif (UniProtKB: Q5VW38). While both
GPR183 and GPR107 do not have the conserved ICL3 tri-basic motif,
GPR183 possesses an additional tri-basic motif ‘KRK’ at the membrane
proximal segment of the C-terminal cytosolic tail. In addition, rodent
gonadotropin-releasing hormone receptors (but not the human coun-
terparts) possess the ICL1 tri-basic motifs. The functions of these ICL1
tri-basic motifs in their respective receptor biosynthesis and trafﬁcking
are currently unknown. In addition to the tri-basicmotif, a YSmotif [54]
is also found in the extracellular N-tail of GPR34. Whether this YS motif
plays any additional regulatory roles in GPR34 biosynthesis is currently
unknown.
Although tri-basic motifs are found in the cytosolic regions of var-
ious membrane-anchored proteins, there seems to be no consensus
as to their roles in biosynthesis and trafﬁcking. For example, tri-
basic motif was shown to prevent ER exit [55,56], facilitate ER exit
[31,55], enable post-Golgi trafﬁcking [32,55,57], interact with a
multi-domain clathrin adaptor protein GGA3 to regulate post-Golgi
trafﬁcking [58], or responsible for differential subcellular targeting
[59]. The motifs can be located in different cytosolic regions such as
cytosolic tail [56,57,59,60], ICL3 [31,32], and ICL1 (this study). The
proximity of the motif to the membrane can confer different func-
tionality in a given protein, too [55]. Currently there is no uniﬁed
rule regarding its location and the functions of tri-basic motif. This
clearly illustrates that their location and function are adapted to
Fig. 12.Oxidation of all four extracellular cysteines is required for the epitope formation. (A) A schematic representation of point mutations introduced to the extracellular loops of GPR34
using the N-terminal FLAG backbone. The location of C127S, C204S, and C299S are in ECL1, ECL2, and ECL3, respectively. C127 and C204 are predicted to form a disulﬁde bridge, but the
redox status of the other two cysteine resides are unknown. (B)Western blotting results for thewildtype FLAG-GPR34 (lane 1), previously tested C46Amutant (lane 2), and the three new
mutants (lanes 3–5). Whole cell lysates were prepared from the transfected HEK293 cells. The lysates were resolved by SDS-PAGE and probed with rabbit anti-FLAG (polyclonal). GPR34
proteins aremarked by an arrowhead. The non-speciﬁc ~15 kDa protein ismarked by asterisk. (C)HEK293 cells expressing themutant constructswere co-stainedwithmouse anti-GPR34
and rabbit anti-FLAG (polyclonal). The construct name is shown on the left of each row. (D) At 48 h post transfection, HEK293 cells expressing the wildtype FLAG-GPR34 construct were
treated with 0 mM, 5 mM, or 10 mM TCEP in Hank's balanced salt solution for 30 min at 37 °C before the cells were ﬁxed, permeabilized, and immunostained. In all conditions, the cells
were co-stained with mouse anti-GPR34 and rabbit anti-FLAG (polyclonal) under permeabilizing conditions. In second and third rows, anti-GPR34 staining signals detected in the
intracellular compartments are pointed by arrowheads. Images were captured by using identical acquisition parameters.
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vidual membrane-anchored proteins.
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